Navigation Links
China-Biotics, Inc. Announces the Results of the 2010 Annual Meeting of Stockholders
Date:3/14/2011

SHANGHAI, March 14, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics" or "the Company"), a leading developer, manufacturer and distributor of probiotics products in China, today announced the results of its 2010 Annual Meeting of Shareholders ("AGM") held on Wednesday, March 9, 2011 for stockholders of record of January 25, 2011, at the Company's Executive Offices at No. 26, Orient Global Headquarter, Lane 118 Yonghe Road, Zhabei District, Shanghai, P.R.China.

At the AGM, Mr. Song Jinan, the Chief Executive Officer and Chairman of the Board of China-Biotics, Dr. Chin Ji Wei, Dr. Du Wen Min and Mr. Simon Yick were elected by stockholders as directors of the Company until the 2011 Annual Meeting of Stockholders.

Stockholders ratified the appointment of BDO Limited as the Company's independent auditors for the fiscal year ending March 31, 2011.

Also at the AGM, stockholders adopted the Company's 2010 Equity Incentive Plan.

Stockholders approved by a non-binding vote the compensation of the Company's named executive officers.

Lastly, a proposal to hold an advisory vote on executive compensation every two years was approved by the shareholders.

China-Biotics' executives provided a brief report outlining the Company's past achievements, growth strategy and business outlook. Management responded to questions from shareholders.

"We are pleased with the results of the 2010 Annual Meeting of Shareholders," said Mr. Jinan Song, Chairman and CEO of China-Biotics, "Adoption of the equity incentive plan will benefit the Company and its shareholders by making it possible to attract and retain key talent. We appreciate our shareholders' support and will continue to create and enhance value as we move ahead with our growth plans and business development strategies."

About China-BioticsChina-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces a proprietary product portfolio. Currently, its retail products are sold over the counter, mainly through large distributors, to pharmacies and supermarkets in Beijing, Shanghai, and Jiangsu and Zhejiang provinces. The Company also sells bulk products to institutional customers such as dairy and animal feed producers as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet the growing demand in China. For more information, please visit http://www.chn-biotics.com.Contact:Travis Cai Chief Financial OfficerChina-Biotics, Inc.traviscai@chn-biotics.comir@chn-biotics.comShiwei Yin/Dixon Chen Grayling646-284-9474shiwei.yin@grayling.comdixon.chen@grayling.com
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011
2. China-Biotics, Inc. Comments on Market Rumors
3. China-Biotics, Inc. Announces US$20 million Share Buyback Program
4. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
5. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
6. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
7. Watson Announces Favorable District Court Ruling in Generic Fentora® Patent Suit
8. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
9. Nephros Announces Completion of Reverse Stock Split
10. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
11. Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... DUBLIN , Dec 9, 2016 Research ... Vaccines Market 2016-2020" report to their offering. ... The global travel vaccines market ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
(Date:12/9/2016)... Dec. 9, 2016  Forge Therapeutics, Inc. today ... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance ... the treatment of bacterial infections including those caused ... as an attractive antibacterial target for more than ... suitable chemical starting points has hampered its progress. ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... Groth Family Insurance, a Washington-based firm offering ... a charity drive to support the family of Cindy Hendrickson, a local mother ... On October 29th of this year, Cindy Hendrickson swerved to avoid an oncoming ...
(Date:12/9/2016)... Ohio (PRWEB) , ... December 09, 2016 , ... ... of miniature, folded, pharmaceutical inserts and outserts. As a means of expanding ... This addition will enable Flottman to individually code professional inserts (PIs) and patient ...
(Date:12/9/2016)... Yorktown Heights, NY (PRWEB) , ... December 09, 2016 , ... ... on Alcoholism and Drug Dependence, Inc. (NCADD) is recommending the film Whispering ... 29 states and the District of Columbia as an education tool in the war ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... An inventor ... amputees to safely ride all types of amusement park rides. , The patent-pending SAFETY ... unit is easy to use and could be set up in a matter of ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pierre Hotel in New York, NY, on December 3rd, to benefit Holy Name ... attended the annual event, which raised over $1 million - the largest event ...
Breaking Medicine News(10 mins):